151 related articles for article (PubMed ID: 32904472)
61. Comparison of the Mean Minimum Dose of Bolus Oxytocin for Proper Uterine Contraction during Cesarean Section.
Beiranvand S; Karimi A; Vahabi S; Amin-Bidokhti A
Curr Clin Pharmacol; 2019; 14(3):208-213. PubMed ID: 31124424
[TBL] [Abstract][Full Text] [Related]
62. Prophylactic Administration of Uterotonics to Prevent Postpartum Hemorrhage in Women Undergoing Cesarean Delivery for Arrest of Labor: A Randomized Controlled Trial.
Balki M; Downey K; Walker A; Seaward G; Carvalho JCA
Obstet Gynecol; 2021 Mar; 137(3):505-513. PubMed ID: 33543897
[TBL] [Abstract][Full Text] [Related]
63. Carbetocin compared to oxytocin in emergency cesarean section: a randomized trial.
Razali N; Md Latar IL; Chan YK; Omar SZ; Tan PC
Eur J Obstet Gynecol Reprod Biol; 2016 Mar; 198():35-39. PubMed ID: 26773246
[TBL] [Abstract][Full Text] [Related]
64. Patients Undergoing Cesarean Delivery After Exposure to Oxytocin During Labor Require Higher Postpartum Oxytocin Doses.
Foley A; Gunter A; Nunes KJ; Shahul S; Scavone BM
Anesth Analg; 2018 Mar; 126(3):920-924. PubMed ID: 28858899
[TBL] [Abstract][Full Text] [Related]
65. Haemodynamic effects of carbetocin and oxytocin given as intravenous bolus on women undergoing caesarean delivery: a randomised trial.
Moertl MG; Friedrich S; Kraschl J; Wadsack C; Lang U; Schlembach D
BJOG; 2011 Oct; 118(11):1349-56. PubMed ID: 21668768
[TBL] [Abstract][Full Text] [Related]
66. [Efficacy of low-dose oxytocin during elective cesarean section].
Palacio FJ; Morillas F; Ortiz-Gómez JR; Fornet I; Bermejo L; Cantalejo F
Rev Esp Anestesiol Reanim; 2011 Jan; 58(1):6-10. PubMed ID: 21348211
[TBL] [Abstract][Full Text] [Related]
67. The risk of postpartum hemorrhage when lowering the oxytocin dose in planned cesarean section, a pilot study.
Stålberg V; Josefsson A; Bladh M; Lilliecreutz C
Sex Reprod Healthc; 2021 Sep; 29():100641. PubMed ID: 34174496
[TBL] [Abstract][Full Text] [Related]
68. Oxytocin injection after caesarean delivery: intravenous or intramyometrial?
Dennehy KC; Rosaeg OP; Cicutti NJ; Krepski B; Sylvain JP
Can J Anaesth; 1998 Jul; 45(7):635-9. PubMed ID: 9717594
[TBL] [Abstract][Full Text] [Related]
69. Randomized double-blind placebo-controlled trial of buccal misoprostol to reduce the need for additional uterotonic drugs during cesarean delivery.
Hernández-Castro F; López-Serna N; Treviño-Salinas EM; Soria-López JA; Sordia-Hernández LH; Cárdenas-Estrada E
Int J Gynaecol Obstet; 2016 Feb; 132(2):184-7. PubMed ID: 26534874
[TBL] [Abstract][Full Text] [Related]
70. [Comparison of carbetocin and oxytocin effectiveness for prevention of postpartum hemorrhage after caesarean delivery].
Brzozowska M; Lisiecki D; Kowalska-Koprek U; Karowicz-Bilińska A
Ginekol Pol; 2015 Feb; 86(2):107-12. PubMed ID: 25807834
[TBL] [Abstract][Full Text] [Related]
71. Oxytocin for preventing postpartum haemorrhage (PPH) in non-facility birth settings.
Pantoja T; Abalos E; Chapman E; Vera C; Serrano VP
Cochrane Database Syst Rev; 2016 Apr; 4(4):CD011491. PubMed ID: 27078125
[TBL] [Abstract][Full Text] [Related]
72. Sublingual misoprostol versus intramuscular oxytocin for prevention of postpartum hemorrhage in Uganda: a double-blind randomized non-inferiority trial.
Atukunda EC; Siedner MJ; Obua C; Mugyenyi GR; Twagirumukiza M; Agaba AG
PLoS Med; 2014 Nov; 11(11):e1001752. PubMed ID: 25369200
[TBL] [Abstract][Full Text] [Related]
73. Intramuscular injection, intravenous infusion, and intravenous bolus of oxytocin in the third stage of labor for prevention of postpartum hemorrhage: a three-arm randomized control trial.
Charles D; Anger H; Dabash R; Darwish E; Ramadan MC; Mansy A; Salem Y; Dzuba IG; Byrne ME; Breebaart M; Winikoff B
BMC Pregnancy Childbirth; 2019 Jan; 19(1):38. PubMed ID: 30658605
[TBL] [Abstract][Full Text] [Related]
74. Systematic review of oxytocin dosing at caesarean section.
Stephens LC; Bruessel T
Anaesth Intensive Care; 2012 Mar; 40(2):247-52. PubMed ID: 22417018
[TBL] [Abstract][Full Text] [Related]
75. Comparison of the benefits and hemodynamic side effects of oxytocin between intravenous infusion with and without bolus injection during caesarean section.
Miyoshi Y; Kaneko S; Suga S; Koga M; Sugimi S; Yamashita H; Yamaguchi M; Yasuhi I
J Obstet Gynaecol; 2021 May; 41(4):557-561. PubMed ID: 32729350
[TBL] [Abstract][Full Text] [Related]
76. Efficacy of Carbetocin versus Oxytocin for the Prevention of Primary Post Partum Haemorrhage after Caesarean Section in Mymensingh Medical College Hospital, Bangladesh.
Hussain CF; Akter SN; Amin SE; Chowdhury UK; Choudhury MF; Zahan F
Mymensingh Med J; 2022 Jan; 31(1):72-79. PubMed ID: 34999683
[TBL] [Abstract][Full Text] [Related]
77. Carbetocin at elective Cesarean delivery: a randomized controlled trial to determine the effective dose.
Cordovani D; Balki M; Farine D; Seaward G; Carvalho JC
Can J Anaesth; 2012 Aug; 59(8):751-7. PubMed ID: 22717890
[TBL] [Abstract][Full Text] [Related]
78. International consensus statement on the use of uterotonic agents during caesarean section.
Heesen M; Carvalho B; Carvalho JCA; Duvekot JJ; Dyer RA; Lucas DN; McDonnell N; Orbach-Zinger S; Kinsella SM
Anaesthesia; 2019 Oct; 74(10):1305-1319. PubMed ID: 31347151
[TBL] [Abstract][Full Text] [Related]
79. Intravenous oxytocin bolus of 2 units is superior to 5 units during elective Caesarean section.
Sartain JB; Barry JJ; Howat PW; McCormack DI; Bryant M
Br J Anaesth; 2008 Dec; 101(6):822-6. PubMed ID: 18845650
[TBL] [Abstract][Full Text] [Related]
80. Oxytocin agonists for preventing postpartum haemorrhage.
Su LL; Chong YS; Samuel M
Cochrane Database Syst Rev; 2007 Jul; (3):CD005457. PubMed ID: 17636798
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
